“Integrated Safety Analysis of Ritlecitinib in Adolescent Patients With Alopecia Areata from the Randomized, Placebo-Controlled ALLEGRO Phase 2b 3 and Ongoing Open-Label Phase 3 ALLEGRO-LT Studies”. SKIN The Journal of Cutaneous Medicine 7, no. 6 (November 13, 2023): s294. Accessed May 17, 2025. https://skin.dermsquared.com/skin/article/view/2377.